‘Cancer, cannabis and me’ – Patient’s moving blog about her journey with stage 4 cancer
Teresa Baker shares her experiences of cancer, cannabis and motherhood to help other patients
24 results for “blog”
Teresa Baker shares her experiences of cancer, cannabis and motherhood to help other patients
Early research suggests CBG-A could support cardiovascular health and reduce oxidative stress.
A previously unrecognised form of reporting bias may be skewing how research on medical cannabis is presented.
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging […]
Dr Sue Clenton, Medical Director of Releaf cannabis clinic explains what it takes to go from a few hundred to thousands of patients, without compromising on the quality of care. […]
The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK.
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention. After over […]
Canadian researchers have developed a unique method to allow for standardized cannabis dosing among different consumption methods. Researchers at UBC Okanagan have created an Index of Cannabis Equivalence (ICE), a […]
Written by Releaf To establish whether medical cannabis is the right option for you, you need to know whether it’s within your budget. Here, Releaf breaks down how much it […]
The charity is hoping to raise £50,000 to support its work in bringing “responsible cannabis regulation” to the UK.
Lyphe is proud to announce the launch of its new low-cost medical cannabis line, Noidecs Vital, designed to address affordability issues for medical patients. Recognising the financial barriers many patients […]
A crowdfunder aims to raise £20,000 to undertake public relations and promotional activity around the existence and benefits of prescription cannabis.
As we mark the fifth anniversary of the legalisation of medical cannabis in the UK, we look back at the last five years.
The US Department of Health and Human Services has recommended that cannabis be classed as a lower risk drug. What does this mean for research, industry and consumers?
It is hoped the findings will lead to a UK-wide study of cannabinoids in endometriosis-associated pain.
Vaping is an increasingly popular way to consume CBD, but how safe is it?
Scottish leaders say it’s time to start approaching drug use from a public health, rather than a criminal justice, perspective.
Hemp Point explores the key differences between RSO and whole-plant CBD .
The world’s most pro-cannabis holiday destinations have just been ranked in a new survey.
Neither current, nor lifetime cannabis use was associated with an increased risk of developing the condition.
Hemp Point’s first foray into cosmetics harnesses the power of hemp in harmony with a full-spectrum of active ingredients.
Researchers found no evidence of an increase in ‘high risk’ use in Canada.
The state ignored pressure from the UN and Amnesty International urging authorities not to proceed.